GlassScriptPhysician profile
Amar Vedamurthy
NPI 1114272283
$34,394.42
in general payments reported to CMS, 2019-2025
7 companies · $28K in 2025
The $28K reported for 2025 was more than what 96% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.63 · 2022: $169 · 2023: $2,120 · 2024: $3,746 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $26K · Travel and Lodging: $5,868 · Food and Beverage: $2,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,632.88 |
| Travel and Lodging | $5,867.77 |
| Food and Beverage | $2,648.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $29,519.96 | 2021-2025 | General - Therapies, Overstitch Endoscopic Suturing System, Axios |
| Olympus Corporation of The Americas | $3,386.17 | 2023-2025 | Disposable Distal Attachment, Single Use Electrosurgical Knife Kd-655, Olympus |
| Cook Incorporated | $632.88 | 2023 | |
| Micro-Tech Endoscopy USA, INC. | $432.04 | 2024 | |
| Medtronic, INC. | $185.00 | 2022-2024 | Barrx |
| Fujifilm Healthcare Americas Corporation | $160.00 | 2023-2024 | |
| Olympus America INC. | $78.37 | 2023 | Endoclot Phs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Vedamurthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.